Daphne Droogh
Papers
2
Total Citations
104
H-Index
2
About
Dr. Daphne Droogh is a pioneering surgical researcher whose work centers on advancing minimally invasive techniques in gastrointestinal and oncologic surgery, with a particular focus on improving patient safety and outcomes. Her most impactful contribution is the landmark AVOID trial (2024), a multicentre, randomised, phase 3 study that demonstrated how indocyanine green near-infrared fluorescence imaging can assess bowel perfusion during minimally invasive colorectal surgery, significantly reducing the risk of anastomotic leakage—a devastating complication. This work, already garnering 84 citations, has rapidly influenced intraoperative decision-making and set a new standard for perfusion assessment. Dr. Droogh has also tackled the contentious debate surrounding minimally invasive versus open pancreatoduodenectomy for resectable neoplasms (2025, 20 citations), providing crucial evidence on safety and recovery outcomes. Her research bridges the gap between innovative technology and clinical practice, directly impacting surgical protocols and patient recovery. By rigorously evaluating these advanced approaches, Dr. Droogh is shaping the future of safer, less invasive cancer surgery, making her a leading voice in the field of surgical innovation and evidence-based practice.
Research Focus
Key Achievements
Top Papers
- 1
- 2